AMGEN INC is 66.7x more valuable than Adaptive Biotechnologies Corp by market capitalization ($182.28 B vs $2.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADPT | AMGN |
|---|---|---|
| Market cap | $2.73 B | $182.28 B |
| US-listed rank | #1887 | #80 |
| Revenue (latest FY) | $276.98M | $36.75B |
| Net income (latest FY) | -$59.50M | $7.71B |
| Net margin | -21.5% | 21.0% |
| P/E (trailing FY) | - | 23.6 |
| SEC filings | 764 | 1,011 |
AMGEN INC is 66.7x more valuable than Adaptive Biotechnologies Corp by market capitalization ($182.28 B vs $2.73 B).
In their latest fiscal years, Adaptive Biotechnologies Corp reported $276.98M in revenue while AMGEN INC reported $36.75B.
Full pages: Adaptive Biotechnologies Corp and AMGEN INC, or browse the full rankings.